Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Resident macrophages reprogram toward a developmental state after acute kidney injury
Jeremie M. Lever, … , Anupam Agarwal, James F. George
Jeremie M. Lever, … , Anupam Agarwal, James F. George
Published January 24, 2019
Citation Information: JCI Insight. 2019;4(2):e125503. https://doi.org/10.1172/jci.insight.125503.
View: Text | PDF
Research Article Immunology Nephrology

Resident macrophages reprogram toward a developmental state after acute kidney injury

  • Text
  • PDF
Abstract

Acute kidney injury (AKI) is a devastating clinical condition affecting at least two-thirds of critically ill patients, and, among these patients, it is associated with a greater than 60% risk of mortality. Kidney mononuclear phagocytes (MPs) are implicated in pathogenesis and healing in mouse models of AKI and, thus, have been the subject of investigation as potential targets for clinical intervention. We have determined that, after injury, F4/80hi-expressing kidney-resident macrophages (KRMs) are a distinct cellular subpopulation that does not differentiate from nonresident infiltrating MPs. However, if KRMs are depleted using polyinosinic/polycytidylic acid (poly I:C), they can be reconstituted from bone marrow–derived precursors. Further, KRMs lack major histocompatibility complex class II (MHCII) expression before P7 but upregulate it over the next 14 days. This MHCII– KRM phenotype reappears after injury. RNA sequencing shows that injury causes transcriptional reprogramming of KRMs such that they more closely resemble that found at P7. KRMs after injury are also enriched in Wingless-type MMTV integration site family (Wnt) signaling, indicating that a pathway vital for mouse and human kidney development is active. These data indicate that mechanisms involved in kidney development may be functioning after injury in KRMs.

Authors

Jeremie M. Lever, Travis D. Hull, Ravindra Boddu, Mark E. Pepin, Laurence M. Black, Oreoluwa O. Adedoyin, Zhengqin Yang, Amie M. Traylor, Yanlin Jiang, Zhang Li, Jacelyn E. Peabody, Hannah E. Eckenrode, David K. Crossman, Michael R. Crowley, Subhashini Bolisetty, Kurt A. Zimmerman, Adam R. Wende, Michal Mrug, Bradley K. Yoder, Anupam Agarwal, James F. George

×

Figure 6

Kidney-resident macrophages downregulate MHCII after injury.

Options: View larger image (or click on image) Download as PowerPoint
Kidney-resident macrophages downregulate MHCII after injury.
(A) The per...
(A) The percentage of R2 kidney-resident macrophages (KRM) positive for MHCII expression in sham and injured (20 minutes bilateral ischemia/reperfusion) mice at varying time points after injury. Mean ± SEM, n = 5–9 from 2 independent experiments, 1-way ANOVA with Sidak’s post-test compared with sham control, *P < 0.05. (B) Flow cytometry 2-parameter histograms gated on R2 KRMs demonstrating MHCII and CD11c expression 6 days after injury compared with sham control. Values are percentage gated. (C) From AKI in parabiosis mice, percentage of chimerism for PMNs, R2 MHCII+, and R2 MHCII– in sham and 3 days after injury. Mean ± SEM, n = 5–10 from 3 independent experiments. (D and E) Absolute numbers (D) and percentage of EdU+ (E) for R2 KRMs, further subset into MHCII+ and MHCII–, indicating changes in cell numbers and proliferative activity during period of 3–4 days after injury (EdU treatment at day 3, endpoint at day 4). Mean ± SEM, n = 5–7 from 2 independent experiments, 2-way ANOVA with Tukey’s post-test compared with sham control, *P < 0.05.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts